BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11232638)

  • 21. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of oleic acid on the expression, activation and activity of gelatinase A produced by oncogene-transformed human bronchial epithelial cells.
    Polette M; Huet E; Birembaut P; Maquart FX; Hornebeck W; Emonard H
    Int J Cancer; 1999 Mar; 80(5):751-5. PubMed ID: 10048978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
    Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
    Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
    Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
    Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.
    Kazes I; Elalamy I; Sraer JD; Hatmi M; Nguyen G
    Blood; 2000 Nov; 96(9):3064-9. PubMed ID: 11049985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.
    Pasco S; Han J; Gillery P; Bellon G; Maquart FX; Borel JP; Kefalides NA; Monboisse JC
    Cancer Res; 2000 Jan; 60(2):467-73. PubMed ID: 10667602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rac1 mediates type I collagen-dependent MMP-2 activation. role in cell invasion across collagen barrier.
    Zhuge Y; Xu J
    J Biol Chem; 2001 May; 276(19):16248-56. PubMed ID: 11340084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
    J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase expression and function during fin regeneration in zebrafish: analysis of MT1-MMP, MMP2 and TIMP2.
    Bai S; Thummel R; Godwin AR; Nagase H; Itoh Y; Li L; Evans R; McDermott J; Seiki M; Sarras MP
    Matrix Biol; 2005 Jun; 24(4):247-60. PubMed ID: 15935631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
    Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
    BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
    Zhang D; Brodt P
    Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C; Chen Z; Li Z; Cen J
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells.
    Hamasaki T; Hattori T; Kimura G; Nakazawa N
    Urol Res; 1998; 26(6):371-6. PubMed ID: 9879815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
    Rao VH; Lees GE; Kashtan CE; Nemori R; Singh RK; Meehan DT; Rodgers K; Berridge BR; Bhattacharya G; Cosgrove D
    Kidney Int; 2003 May; 63(5):1736-48. PubMed ID: 12675849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
    Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
    J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.